Skip to main content
Log in

News from ESC

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Moeremans K, Lamotte M, Wittrup-Jensen K, Pignone M.The heath economic value of aspirin in the primary prevention of cardiovascular disease in diabetic patients ESC Congress 2009: Annual Congress of the European Society of Cardiology: abstr. P1470, 29 Aug 2009. Available from: URL: http://www.escardio.org

  2. Rublee D, Rieber J, Giannitsis E, Berger K, Ehlken B, Asukai Y, Plesnila-Frank C, Mardekian J.Lifetime incremental effectiveness and cost-effectiveness of high-dose statin therapy versus standard-dose statin therapy in German patients with recent myocardial infarction ESC Congress 2009: Annual Congress of the European Society of Cardiology: abstr. 4978, 29 Aug 2009. Available from: URL: http://www.escardio.org

  3. Zomer E, Liew D, Owen A, Magliano D, Reid C.The impact of achieving risk factor targets on CVD events in a community-based study. ESC Congress 2009: Annual Congress of the European Society of Cardiology: abstr. 979, 29 Aug 2009. Available from: URL: http://www.escardio.org

  4. Holstenson E, Morais E, Berg J, Nieuwlaat R, Ringborg A, Crijns H.Euro heart survey on AF: Costs of atrial fibrillation (AF) for ATHENA-like patients in Greece, Italy, Poland, Spain and the Netherlands. ESC Congress 2009: Annual Congress of the European Society of Cardiology: abstr. P1498, 29 Aug 2009. Available from: URL: http://www.escardio.org

  5. Merino JL, Rodriguez-Barrios JM, Brosa M, Tsintzos S.Cost-effectiveness model of Implantable Cardiac Monitors (ICM) for patients treated with radiofrequency catheter ablation for atrial fibrillation (PAAF). ESC Congress 2009: Annual Congress of the European Society of Cardiology: abstr. P755, 29 Aug 2009. Available from: URL: http://www.escardio.org

  6. Wynn GJ, Seetha Rammohan H, Jakka N, Hawkins NM, Burgess MI.The price of being BEAUTIFUL: Does the benefit of Ivabradine in heart failure justify the cost? ESC Congress 2009: Annual Congress of the European Society of Cardiology: abstr. P2515, 29 Aug 2009. Available from: URL: http://www.escardio.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

News from ESC. Pharmacoecon. Outcomes News 588, 3–4 (2009). https://doi.org/10.2165/00151234-200905880-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905880-00004

Keywords

Navigation